INTRODUCTION
Increased survival for very low birthweight (VLBW) infants (weighing less than 1500 g at birth) has led to an increase in retinopathy of prematurity (ROP) incidence 1 and ROP-induced blindness. 2 VLBW infants are at increased risk of ROP for at least two reasons. First, normal development of the retinal vascular system may be altered for the preterm infant growing in an extrauterine environment. Second, oxygen toxicity resulting from required oxygen administration to the VLBW infant is one of the factors that lead to abnormal development of the vascular tissue, resulting in retinal traction and retinal detachment. 3 Investigations of clinical interventions to reduce the development of ROP have not identified significant clinical practices that may
INTRODUCTION:
With the increased survival of very low birthweight ( VLBW ) infants, weighing less than 1500 g at birth, the incidence of retinopathy of prematurity ( ROP ) , a significant cause of blindness among children in the United States, is also increasing. Preterm infants with a positive diagnosis of ROP during the perinatal period are at increased risk for ocular abnormalities and for deficits in visual function during later periods of development. Human milk has many antioxidant constituents including inositol, vitamin E, and beta -carotene that may protect against the development of ROP.
OBJECTIVE:
The objective of this study was to examine the effect of human milk feedings on the incidence of ROP among VLBW infants.
STUDY DESIGN:
Observational cohort study.
PARTICIPANTS:
We identified 283 VLBW infants admitted to the Georgetown University Medical Center Neonatal Intensive Care Unit ( NICU ) from January 1992 through September 1993. All infants surviving to receive enteral feeding and ophthalmologic examinations for ROP ( n = 174 ) were included in the analysis.
METHODS:
Type of feeding ( human milk versus exclusive formula ) , presence of ROP, and potential confounding variables were abstracted retrospectively from medical records. ROP was present if any stage of ROP was diagnosed at any age during the initial NICU hospitalization; each case was counted once based on the worse severity of ROP in either eye. Multiple logistic regression was used to control for confounders.
MAIN OUTCOME MEASURE: ROP.
RESULTS:
Major predictors of ROP were similar in both feeding groups including gestational age, days on mechanical ventilation, and total number of days on supplemental oxygen. The incidence of ROP differed significantly by type of feeding ( human milk À 41.0% vs. formula À 63.5%, p = 0.005 ) . Human milk feeding independently correlated with a reduced odds of ROP ( OR: 0.42, 95% CI: 0.19 to 0.93 ) ( p = 0.03 ) , controlling for gestational age, duration of supplemental oxygen therapy, 5 -minute Apgar score, and race. Human milk feeding independently correlated with a reduced odds of ROP ( OR: 0.46, 95% CI: 0.18 to 0.91 ) ( p = 0.03 ) , controlling for birthweight, duration of supplemental oxygen therapy, 5 -minute Apgar score, and race.
CONCLUSION:
Human milk feeding among VLBW infants was associated with a lower incidence of ROP compared to exclusively formula -fed VLBW infants after adjusting for confounding variables. 
Original Article
For example, recent research findings indicate that a reduction in ambient light exposure was not effective in preventing ROP. 4 Several major controlled clinical trials of vitamin E therapy have produced inconsistent findings. 5, 6 Inositol administration to preterm infants, however, has resulted in a lower incidence of ROP. 7 Inositol is a naturally occurring component of human milk and is not routinely added to infant formula.
Recently, the American Academy of Pediatrics' Work Group on Breastfeeding has extended its breastfeeding recommendation to include preterm infants. 8 The nutritional and immunological benefits of providing human milk to VLBW infants have been described elsewhere. 9 -12 The protein content of preterm human milk is higher than term breast milk. Human milk from mothers of preterm infants is also higher in calories, sodium, and chloride than milk from mothers of term infants. In particular, the antioxidant components of human milk, including inositol, vitamin E, and beta-carotene may protect against the development of ROP.
There have been suggestions in the medical literature that human milk may reduce the incidence ROP among VLBW infants. Early medical record reviews have indicated a possible association between the provision of human milk to preterm infants and a decreased incidence of ROP. In the late 1940s, investigators in a Chicago hospital reported a remarkably low incidence of ROPapproximately 20% of prevailing rates at the time. 13 The high rate of providing human milk to preterm infants in this nursery was one aspect of care cited by observers that may have resulted in the decreased incidence of ROP. Other unmeasured factors that varied between hospital nurseries or between human milk-fed and formula-fed infants, however, were not addressed in this study and may have accounted for the low incidence of ROP in this particular nursery.
Similarly, a retrospective review of the medical records of 385 preterm births in Philadelphia from 1979 to 1981 indicated that even partial human milk feeding was associated with half the incidence of ROP compared to preterm infants fed formula alone. 14 The absence of taurine from the preterm infant formula used for infants in this study sample was considered to be the factor underlying the observed protective effect of human milk against the development of ROP. The amount of transfused blood relative to the body weight of the newborn, presumably a marker for severity of illness, was the only confounding variable considered in the analysis. Without adjustment for important predictors of ROP including gestational age and oxygen therapy, these findings are inconclusive.
Apart from the two studies reported above, prior research investigating the relation between human milk feedings and ROP has been, for the most part, anecdotal or preliminary. Moreover, this research has lacked adequate control of confounders to demonstrate an independent association between human milk feeding and ROP. The current study was specifically designed to examine the effect of human milk feedings on the incidence of ROP among hospitalized, VLBW infants controlling for potential confounding variables.
METHODS

Study Sample
The study sample included all preterm infants weighing up to 1500 g at birth and hospitalized in the Neonatal Intensive Care Unit (NICU) at the Georgetown University Medical Center from January 1992 through September 1993 (n=283). Of these infants, 65 died before the start of enteral feedings and 38 did not receive eye examinations to determine ROP status. These 103 infants and infants whose medical records were not available from the medical records department (n=6) were excluded from the study. The total sample for which the effect of providing human milk on ROP incidence could be analyzed was 174 VLBW infants -sufficient to detect a 50% decrease in ROP morbidity with a power of 0.80 and a significance level of 0.05, assuming a difference in ROP incidence of 47% in the formula-fed group and 23% in the human milk-fed group. A total of 100 sample infants received some breast milk feedings, whereas 74 were exclusively formula-fed.
The proportion of infants excluded because they did not receive eye examinations to determine ROP status prior to discharge did not differ significantly between the two feeding groups; human milk: 19% excluded and formula: 17% excluded. The excluded infants were at lower risk for ROP based on gestational age (mean of 29.1 weeks' gestation for excluded infants compared to 27.8 for sample infants). They also had shorter lengths of nursery stay and less days in which they received oxygen therapy. This difference may reflect an increased proportion of larger, healthier infants whose first ROP exam was deferred until after discharge. The absence of pediatric ophthalmologists at some reverse transport hospitals may have led to ROP screening exams being deferred until postdischarge for lower-risk infants. The tendency not to authorize ROP exams until after discharge for larger, healthier infants was followed by some HMOs providing coverage to infants in this study sample. This practice may be related to the cost difference between ROP exams conducted on an inpatient versus outpatient basis at the HMO facility. Another factor may have been continuity of care, which might underlie the decision to defer the first ROP exam until after discharge to the HMO ophthalmologist who would also be performing subsequent exams after discharge.
The Georgetown University Medical Center is a tertiary care center, accepting maternal and infant transports. The National Capital Lactation Center and the Milk Bank at the Georgetown University Medical Center provide support to mothers who choose to provide expressed human milk to their infants. Extensive facilities staffed by Lactation Consultants, who are all registered nurses, are available to support the expression and storage of human milk. As a result, the rate of breastfeeding among mothers of VLBW, preterm infants is relatively high at this institution: 57.0% for this study sample compared to the rate of 36% reported nationally. 15 This study was reviewed and approved by the Institutional Review Board at the Georgetown University Medical Center.
Definition of Human Milk Feedings
All human milk-fed infants received milk from their own mothers with supplemental formula feedings when human milk was not available. Expressed human milk was provided fresh or frozen for future use at B208C. Frozen milk was thawed for each use. Human milk was fortified with Human Milk Fortifier 7 , Polycose 7 , or MCT 7 oil, as clinically indicated. Human milk supplements have been developed by commercial infant formula companies to fortify breast milk from mothers of preterm infants to compensate for the nutritional deficiencies recognized in preterm human milk and to foster appropriate growth. General guidelines for the use of human milk fortifiers are to supplement breast milk from the time that enteral feedings are established and to continue use until the preterm infant weighs approximately 2000 g (Wink, 1989). Most mothers who initiated human milk feedings continued for the duration of their infant's hospitalization.
Human milk feeding was defined as feeding any amount of human milk, regardless of supplementation with formula. Human milk feedings were classified according to a standard international definition 16 as follows: full (100% human milk); partial: high (80% to 99% human milk); partial: medium (20% to 79% human milk); and partial: low ( <20% human milk). Categories of high human milk consumption (80% or greater human milk) and partial human milk consumption (79% or less human milk) were also constructed. Formula feeding was defined as exclusive formula feeding. Similac Special Care premature infant formula was used in formula-fed infants and as a supplement to breastfed infants. The same preterm infant formula was provided to all formula-fed infants.
Definition of ROP All routine ophthalmologic examinations recorded during NICU hospitalization were retrospectively abstracted from the medical record to document cases of ROP. ROP was present if any stage of ROP was diagnosed at any age during the initial NICU Hylander et al.
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hospitalization; each case was counted once based on the worst severity of ROP in either eye. To obtain complete data regarding the occurrence of ROP, medical records were abstracted at reverse transport hospitals for transported mothers and infants, including all ophthalmologic examinations conducted until NICU discharge. At the Georgetown University Medical Center, all ophthalmologic examinations were conducted by pediatric ophthalmologists following an established protocol. The first examination took place at 4 to 6 weeks of age for all infants weighing 1500 g or less at birth. Subsequent examinations were conducted at the discretion of the ophthalmologist, based on the findings from the first examination, the infant's age, gestational maturity, and risk status. Ophthalmologic examinations were continued to screen for ROP until the retinal vasculature was assessed to be completely mature.
Statistical Analysis
The analysis of data for the study sample focused on comparing the incidence of ROP among human milk-and formula-fed infants, and potential confounders. Data were analyzed using Statview and JMP (SAS Institute). A bivariate analysis was first performed to determine the degree of comparability between the human milk-fed and formula-fed infants and to identify differences between these groups. Significant (p<0.05) differences were determined through unpaired t-tests for continuous variables and -squared analysis for categorical variables. Associations between potential confounding variables and the presence of ROP were also identified through this bivariate analysis. We utilized multiple logistic regression analysis to adjust for the effects of variables identified through the bivariate analysis to be associated with either type of feeding or the presence of ROP. The variables included in the multiple regression analysis are listed in Table 1 .
Logistic regression models were estimated by a multistep process that considered all factors directly associated with either type of feeding or the presence of ROP. Among sets of highly correlated variables (such as birthweight and gestational age), the variable most strongly correlated with ROP, as assessed by the magnitude of the odds ratio, was included in the analysis. Next, a full model was estimated, and all variables that were not significantly predictive of ROP (p>0.1) were excluded. Only variables with a p value <0.05 in a multivariate analysis of the Full Model were retained in the Reduced Logistic Regression Model ( Table 2 ). The results for the full model are not reported here, but may be obtained from the authors.
Missing data, while comprising only 2.4% of the total number of data elements in the analytical file, occurred in one sixth of the cases. To avoid substantial data loss in the multivariate regression analyses, where all variables must have values, the missing values were imputed. There were no missing values for feeding method, the major predictor, and ROP, the major outcome; only covariates required imputation. Missing values for categorical data were included in the reference category (the most commonly occurring category) or were assigned the group median for missing values on continuous variables. Through this imputation process (overall, 4% of cases required imputation), all eligible cases were included in the analysis. This is a conservative approach to missing data, which maximized the available sample for analysis. The results of the logistic regression analysis for the nonimputed data were similar to the reported results for the imputed data; using nonimputed data, the full and reduced models were the same and the odds ratios for all the model variables were not significantly different; in fact, they were nearly identical.
RESULTS
Characteristics of the Study Sample
Major predictors of ROP, including gestational age, were similar between the human milk-fed and exclusively formula-fed infants.
The only infant variable that differed significantly between the two groups was birthweight: infants in the human milk-fed group weighed, on average, 96 g more at birth than infants who were formula-fed (Table 3) .
Mothers who chose to provide human milk to their VLBW infants were more likely to be non-white, married, employed, have health insurance, receive prenatal care, and avoid alcohol, smoking, or drug use during pregnancy than mothers who provided infant formula exclusively to their VLBW infants. These differences indicated the need to account for their potential influence on ROP incidence in the logistic regression analysis. Factors associated with the presence of ROP are listed in Table 4 .
Incidence of ROP
The overall incidence of ROP for all VLBW infants in this study sample was 51.0%, and is comparable to other reported ROP incidence rates. 17 The unadjusted incidence of ROP was significantly lower for human milk-fed infants (41%) than for exclusively formula-fed infants (63.5%) ( Table 4) . Table 5 displays the breakdown of the four categories of human milk feedings and formula by the four stages of ROP. There were no cases of stage 3 or 4 ROP among VLBW infants who were exclusively human milk-fed or who were fed at least 80% human milk. Although the differences by percentage of human milk suggested a trend toward lower severity of ROP in the infants with the greatest percentage of human milk feedings, they did not reach statistical significance. Figure 1 displays the severity of ROP by feeding groups. None of the infants receiving human milk required laser therapy; all five infants requiring laser therapy for threshold ROP were in the formula-fed group.
Logistic Regression
The logistic regression analysis indicated that five factors were significantly related to ROP (Table 2) . For every additional week of gestational age, the odds of ROP were reduced by 32%; for every additional day of oxygen therapy, the odds of ROP increased by 2%; for every additional unit of increase in Apgar score at 5 minutes, the odds of ROP decreased by 40%; being non-white increased the odds of developing ROP by 200%; and being human milk-fed decreased the odds of ROP by 58%. Type of feeding was an independent predictor of ROP, after accounting for the influence of the other significant variables. Since birthweight varied significantly between the human milk-and formula-fed infants, reduced logistic regression models with birthweight substituted for gestational age were also estimated. Human milk feeding was independently associated with a reduced odds of ROP (OR=0.46, 95% CI: 0.18 to 0.91; p=0.028), controlling for birthweight, 5-minute Apgar score, race, and duration of supplemental oxygen therapy.
A dose-response effect was not observed when categories of human milk were entered into the logistic regression models. This finding may be due to the small numbers of VLBW infants in the categories of high human milk consumption (80% or greater human milk feedings) in this sample.
DISCUSSION
The results of this study indicate that the incidence of ROP was significantly reduced in human milk-fed VLBW infants compared to exclusively formula-fed VLBW infants. The major independent predictors of ROP identified in the logistic regression, gestational age, and total oxygen days are findings consistent with other studies. 18 -20 In our sample, non-white infants were at higher risk of developing any ROP. Previous studies have indicated that white infants had a higher rate of progression to threshold ROP as defined by stage 3 or greater, after controlling for confounding variables. 21 Our sample, however, was not large enough to detect statistically significant differences in the incidence of stage 3 or greater ROP between white and non-white infants.
Our finding that human milk-fed infants were at lower risk of developing any ROP may have clinical significance despite our inability to detect statistically significant differences in the incidence of stage 3 or greater ROP between human milk-and formula-fed infants. Preterm infants with a positive diagnosis of ROP during the perinatal period are at increased risk for ocular abnormalities and for deficits in visual function during later periods of development; infants for whom ROP is diagnosed even if the ROP later resolves are more likely to develop visual deficits including myopia 22,23 and strabismus. 24 The incidence and severity of myopia have also been associated with a positive diagnosis of ROP. 23 When myopic preterm infants with ROP were compared to myopic premature infants without ROP, the infants with ROP tended to have a greater degree of myopia, which persisted, whereas the myopia experienced by infants without ROP tended to decrease in degree during the first year of life. 22 These findings, indicating that preterm infants with a positive diagnosis of ROP during the perinatal period are at increased risk for ocular abnormalities and for deficits in visual function during later periods of development, support the provision of human milk based on the association with a lower incidence of any ROP in our study.
The physiological mechanism through which breast milk may protect against the development of ROP may be the antioxidant properties of human milk as well as the potential contribution of human milk to normal retinal development. Specifically, the antioxidant constituents of human milk include inositol, vitamin E, and beta-carotene. A lower incidence of ROP has been reported in inositol-supplemented preterm infants. 7 In addition to the antioxidant properties, other components of human milk, including essential fatty acids, may contribute to normal visual development. 25 Essential fatty acids, specifically DHA, have been found to improve visual acuity in preterm infants. 26 DHA naturally occurs in human milk, but it is not routinely added to preterm infant formulas. Evidence suggests that deficits in DHA in combination with underdeveloped antioxidant protection may contribute to the neurovisual developmental disorders, including ROP, that are experienced by preterm infants. 27 A recent meta-analysis of randomized clinical trials of vitamin E prophylaxis was designed to test the hypothesis that increased serum concentrations of vitamin E reduce the incidence of severe ROP. 28 The results indicated a reduction in the incidence of stage 3+ ROP associated with vitamin E administration. The efficacy and safety of administering vitamin E to preterm infants to prevent ROP, however, have not been established. The methodological limitations of this meta-analysis prevented an assessment of the potential adverse effects of vitamin E therapy; therefore, the authors recommend further study. In the current study, the antioxidant components of human milk may have protected the VLBW infant against the development of ROP without any evident adverse effects.
One limitation of our study relates to the generalizability of the findings. The study was limited to one tertiary center where there are extensive resources through the Milk Bank and Lactation Center available to mothers who choose to provide human milk to their VLBW infants. Nevertheless, as a result of these resources, the relatively high rate of providing human milk to VLBW infants in this study sample (59.0%) may have resulted in reducing the gap in the differences that commonly characterize women who chose to provide human milk to their VLBW infants and women who decide to provide formula. Although these differences persisted to an extent in this sample, they were not generally reflected in differences in infant factors that may confound the relation between infant feeding type and ROP. In fact, the infants whose mothers chose to provide human milk were similar to the infants whose mothers provided infant formula in this sample. There may, nevertheless, have been other unconsidered potential confounding factors that may have differed between the two feeding groups.
Our study was also limited by our definition of infant feeding in that it did not include the duration of feeding. Data on the actual adjusted (per kilogram) volume of human milk provided to VLBW infants would be useful to detect a potential dose-response relationship between the amount of human milk provided and the incidence or severity of ROP. While our results were suggestive of a dose-response relation of percentage of human milk feedings and severity of ROP, the numbers are too small to make any conclusion here. Future research should include a prospective study design to allow for more complete data on amount of breast milk fed than the current retrospective design. A multicenter study or an extension of the enrolment period with a larger sample would enable researchers to expand their focus beyond the presence or absence of ROP and examine the possible effect of human milk feedings on the severity of ROP and the long-term sequelae of ROP.
To summarize, in this study, we have attempted to address the methodological limitations of prior studies, including lack of control for differences between human milk-and formula-fed infants, through our study design and statistical adjustment. Our findings suggest a protective effect of human milk feedings against ROP after controlling for potential confounding variables. Clinical interventions to reduce the development of ROP have been limited because many identified risk factors for ROP are difficult to alter in clinical practice. The ability to limit supplemental oxygen administration is necessarily constrained by the need to safeguard the life and neurological status of the VLBW infant. We have identified a potential preventive measure, the provision of maternally expressed human milk, which may reduce the development of ROP without accompanying adverse effects.
